Dividend is ok, but PTSC should still focus on topics dicussed here

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

s402005

Rank: Treasurer [?]

Points: 5795 [?]

Votes: 78 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Dividend is ok, but PTSC should still focus on topics dicussed here

posted on Feb 22, 2007 11:38AM

many times:

- solution for S/L warrants, options.....

- establishing of there own business modell

- product development

- reduction of the free float and still buying back sahres

- preparation to move to another stock exchange

Don't get me wrong, I am happy. However, we should not make the same mistakes as last year!